Meta Pixel

News and Announcements

Human trials begin in Brisbane, Melbourne for treatment of deadly brain tumours

  • Published November 26, 2014 9:51AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Source: ABC News; Published: Tuesday, 25th November 2014

A world-first human trial set to begin in Brisbane and Melbourne has the potential to be one of the biggest breakthroughs in the treatment of brain cancer, researchers say.

Scientists are confident an antibody created to prolong the lives of people suffering from almost-always fatal Glioblastoma tumour may even offer a cure.

As part of the trial, 20 patients with the recurrent brain tumour will be treated at the Royal Brisbane and Women’s Hospital and the Austin Hospital in Melbourne with the antibody that specifically targets a cancer protein on the surface of the tumour cells.

QIMR Berghofer Medical Research Institute’s professor Andrew Boyd discovered that cancer protein, EphA3, more than 20 years ago.

He also developed the antibody that has been shown to specifically target cancer cells which express EphA3.

To read the full article please click here.

Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy

Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Join over 45,000+ sophisticated investors

Join Now